These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 16584923

  • 1. The role of antibody-mediated immunity in defense against Mycobacterium tuberculosis: advances toward a novel vaccine strategy.
    Glatman-Freedman A.
    Tuberculosis (Edinb); 2006; 86(3-4):191-7. PubMed ID: 16584923
    [Abstract] [Full Text] [Related]

  • 2. Advances in antibody-mediated immunity against Mycobacterium tuberculosis: implications for a novel vaccine strategy.
    Glatman-Freedman A.
    FEMS Immunol Med Microbiol; 2003 Oct 24; 39(1):9-16. PubMed ID: 14556990
    [Abstract] [Full Text] [Related]

  • 3. [Novel vaccines against M. tuberculosis].
    Okada M.
    Kekkaku; 2006 Dec 24; 81(12):745-51. PubMed ID: 17240920
    [Abstract] [Full Text] [Related]

  • 4. An attenuated Salmonella-vectored vaccine elicits protective immunity against Mycobacterium tuberculosis.
    Wang QL, Pan Q, Ma Y, Wang K, Sun P, Liu S, Zhang XL.
    Vaccine; 2009 Nov 12; 27(48):6712-22. PubMed ID: 19733584
    [Abstract] [Full Text] [Related]

  • 5. Tuberculosis vaccine research: the impact of immunology.
    Barker LF, Brennan MJ, Rosenstein PK, Sadoff JC.
    Curr Opin Immunol; 2009 Jun 12; 21(3):331-8. PubMed ID: 19505813
    [Abstract] [Full Text] [Related]

  • 6. Enhanced immunoprotective potential of Mycobacterium tuberculosis Ag85 complex protein based vaccine against airway Mycobacterium tuberculosis challenge following intranasal administration.
    Giri PK, Verma I, Khuller GK.
    FEMS Immunol Med Microbiol; 2006 Jul 12; 47(2):233-41. PubMed ID: 16831210
    [Abstract] [Full Text] [Related]

  • 7. Role of interleukin-12 family cytokines in the cellular response to mycobacterial disease.
    Méndez-Samperio P.
    Int J Infect Dis; 2010 May 12; 14(5):e366-71. PubMed ID: 19762261
    [Abstract] [Full Text] [Related]

  • 8. Mycobacterial glycoconjugates as vaccine candidates against tuberculosis.
    Källenius G, Pawlowski A, Hamasur B, Svenson SB.
    Trends Microbiol; 2008 Oct 12; 16(10):456-62. PubMed ID: 18774297
    [Abstract] [Full Text] [Related]

  • 9. Immunogenicity and protective efficacy of a DNA vaccine encoding the fusion protein of mycobacterium heat shock protein 65 (Hsp65) with human interleukin-2 against Mycobacterium tuberculosis in BALB/c mice.
    Wang LM, Bai YL, Shi CH, Gao H, Xue Y, Jiang H, Xu ZK.
    APMIS; 2008 Dec 12; 116(12):1071-81. PubMed ID: 19133010
    [Abstract] [Full Text] [Related]

  • 10. Interaction of Mycobacterium tuberculosis with the host: consequences for vaccine development.
    Dietrich J, Doherty TM.
    APMIS; 2009 May 12; 117(5-6):440-57. PubMed ID: 19400867
    [Abstract] [Full Text] [Related]

  • 11. Rational design of vaccines against tuberculosis directed by basic immunology.
    Reece ST, Kaufmann SH.
    Int J Med Microbiol; 2008 Jan 12; 298(1-2):143-50. PubMed ID: 17702652
    [Abstract] [Full Text] [Related]

  • 12. The search for a tuberculosis vaccine: an elusive quest?
    Nagelkerke NJ, de Vlas SJ, Mahendradhata Y, Ottenhoff TH, Borgdorff M.
    Tuberculosis (Edinb); 2006 Jan 12; 86(1):41-6. PubMed ID: 16253559
    [Abstract] [Full Text] [Related]

  • 13. A review of vaccine research and development: tuberculosis.
    Girard MP, Fruth U, Kieny MP.
    Vaccine; 2005 Dec 30; 23(50):5725-31. PubMed ID: 16153751
    [Abstract] [Full Text] [Related]

  • 14. B cells and antibodies in the defense against Mycobacterium tuberculosis infection.
    Achkar JM, Chan J, Casadevall A.
    Immunol Rev; 2015 Mar 30; 264(1):167-81. PubMed ID: 25703559
    [Abstract] [Full Text] [Related]

  • 15. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec 30; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 16. Human macrophage host defense against Mycobacterium tuberculosis.
    Liu PT, Modlin RL.
    Curr Opin Immunol; 2008 Aug 30; 20(4):371-6. PubMed ID: 18602003
    [Abstract] [Full Text] [Related]

  • 17. Tuberculosis subunit vaccine development: impact of physicochemical properties of mycobacterial test antigens.
    Sable SB, Plikaytis BB, Shinnick TM.
    Vaccine; 2007 Feb 19; 25(9):1553-66. PubMed ID: 17166640
    [Abstract] [Full Text] [Related]

  • 18. Tuberculosis subunit vaccine design: the conflict of antigenicity and immunogenicity.
    Sable SB, Kalra M, Verma I, Khuller GK.
    Clin Immunol; 2007 Mar 19; 122(3):239-51. PubMed ID: 17208519
    [Abstract] [Full Text] [Related]

  • 19. Induction of a protective response with an IgA monoclonal antibody against Mycobacterium tuberculosis 16kDa protein in a model of progressive pulmonary infection.
    López Y, Yero D, Falero-Diaz G, Olivares N, Sarmiento ME, Sifontes S, Solis RL, Barrios JA, Aguilar D, Hernández-Pando R, Acosta A.
    Int J Med Microbiol; 2009 Aug 19; 299(6):447-52. PubMed ID: 19157977
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.